p-Chlorophenacyl bromide → Methyl[5-(tert-butyl)-2-(4-chlorobenzoyl)-1h-indol-3-yl]acetate
Reaction equation
[C:1]([C:5]1[CH:6]=[CH:7][C:8]([NH:17]S(C2C=CC(C)=CC=2)(=O)=O)=[C:9]([CH:16]=1)/[CH:10]=[CH:11]/[C:12]([O:14][CH3:15])=[O:13])([CH3:4])([CH3:3])[CH3:2].[Cl:28][C:29]1[CH:38]=[CH:37][C:32]([C:33](=[O:36])[CH2:34]Br)=[CH:31][CH:30]=1>>[CH3:15][O:14][C:12](=[O:13])[CH2:11][C:10]1[C:9]2[C:8](=[CH:7][CH:6]=[C:5]([C:1]([CH3:2])([CH3:3])[CH3:4])[CH:16]=2)[NH:17][C:34]=1[C:33](=[O:36])[C:32]1[CH:37]=[CH:38][C:29]([Cl:28])=[CH:30][CH:31]=1Participants
3
Procedure
The title compound was prepared according to the procedure described in Example 57 from methyl trans-5-tert-butyl-2-(p-toluenesulfonylamino)cinnamate (Example 143, step 2) and 4-chlorophenacyl bromide.
Sources & evidence
- ORD record
- ord-027317ece64d4d9fa52ac0146ae93e23
- Source dataset
- uspto-grants-2003_08
- Patent number
- US06608070B1
Reaction notes
Loading…